½ÃÀ庸°í¼­
»óǰÄÚµå
1598792

¹è´¢¹é ½ÃÀå : ¹é À¯Çü, ¿ëµµ, ¿ë·®, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Urinary Drainage Bags Market by Bag Type (Leg Bag, Regular or Large Bag), Usage (Disposable, Reusable), Capacity, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¹è´¢¹é ½ÃÀåÀº 2023³â 14¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 15¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 6.64% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 23¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µµ´¢¹é ½ÃÀåÀº ¼ö¼ú, ¸¸¼ºÁúȯ ¶Ç´Â ³ëÈ­·Î ÀÎÇØ µµ¿òÀÌ ÇÊ¿äÇÑ È¯ÀÚÀÇ ¼Òº¯À» ȸ¼öÇϵµ·Ï ¼³°èµÈ Á¦Ç°À¸·Î Á¤Àǵ˴ϴÙ. ÀÌ °¡¹æ¿¡´Â ´Ù¸® °¡¹æ, ħ´ë ¿· °¡¹æ, ´ë¿ë·® ¹è¼ö °¡¹æ µî ´Ù¾çÇÑ À¯ÇüÀÇ °¡¹æÀÌ ÀÖÀ¸¸ç ´Ù¾çÇÑ È¯ÀÚÀÇ ¿ä±¸¿Í ȯ°æÀ» ÃæÁ·½Ã۱â À§ÇØ ´Ù¾çÇÑ À¯ÇüÀÇ °¡¹æÀÌ ÀÖ½À´Ï´Ù. ¹è´¢ ÁÖ¸Ó´ÏÀÇ Çʿ伺Àº º´¿ø, ¿Ü·¡ ¹× ÀçÅà °£È£ ÇöÀå¿¡¼­ ȯÀÚ¿¡°Ô Æí¾ÈÇÔÀ» Á¦°øÇÏ°í °£º´Àο¡°Ô Æí¸®ÇÔÀ» Á¦°øÇÏ´Â Áß¿äÇÑ ¿ëµµ¿¡¼­ ºñ·ÔµË´Ï´Ù. °í·ÉÈ­ Àα¸ÀÇ Áõ°¡¿Í ¹è´¢ Àå¾ÖÀÇ Áõ°¡·Î ÀÎÇØ ½ÃÀåÀÇ ÃÖÁ¾ »ç¿ë ¹üÀ§´Â Áø·á¼Ò, º´¿ø, Àå±â¿ä¾ç½Ã¼³·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â »õ·Î¿î ¼ºÀå ¿äÀÎÀ¸·Î´Â Ä«Å×ÅÍ Àç·áÀÇ ±â¼ú ¹ßÀü, ȯÀÚ ÆíÀǼº Çâ»ó, °¨¿° À§Çè °¨¼Ò µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·áºñ Áõ°¡¿Í COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇÑ ÀçÅà °£È£¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Á¦Ç° ȸ¼ö, ¿ä·Î °¨¿° °¡´É¼º, »ç¿ë»óÀÇ ºÒÆíÇÔ°ú ³«ÀÎ µîÀÇ Á¦¾àÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸Çϰí, ½ÃÀå¿¡´Â ¸î °¡Áö ±âȸ°¡ ÀÖ½À´Ï´Ù. ½º¸¶Æ® ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» °®Ãá Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϸé ȯÀÚ °á°ú¿¡ Å« µµ¿òÀÌ µÉ ¼ö ÀÖÀ¸¸ç, ģȯ°æÀûÀÌ°í »ýºÐÇØ¼º ¼ÒÀçÀÇ Çõ½ÅÀ» ÅëÇØ Á¦Ç°À» Áö¼Ó°¡´ÉÇÑ °üÇà°ú ÀÏÄ¡½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ç¿ë ÆíÀǼº°ú »ç·Á ±íÀ½À» ¿ì¼±½ÃÇÏ´Â ´õ ³ªÀº »ç¿ëÀÚ Á᫐ µðÀÚÀÎÀ» °³¹ßÇÏ¸é ½ÃÀå ¼ö¿ë¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¼±µÎ¸¦ ³ë¸®´Â ÁÖ¿ä ±â¾÷µé¿¡°Ô Ç×±Õ ±â¼ú ¹× ½Ç½Ã°£ ¸ð´ÏÅ͸µÀ» À§ÇÑ ÅëÇÕ µðÁöÅÐ ¼Ö·ç¼ÇÀÇ Çõ½ÅÀ» À§ÇÑ R&D ÅõÀڴ ƯÈ÷ ȨÄÉ¾î ¼Ö·ç¼Ç¿¡¼­ °­·ÂÇÑ ¹ßÀüÀÇ ±æÀ» Á¦½ÃÇÕ´Ï´Ù. º¯È­ÇÏ´Â ½ÃÀå »óȲÀ» È¿°úÀûÀ¸·Î ÆÄ¾ÇÇϱâ À§Çؼ­´Â ±ÔÁ¦ »óȲÀ» Áö¼ÓÀûÀ¸·Î ÆÄ¾ÇÇϰí ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿ÍÀÇ ÆÄÆ®³Ê½ÊÀ» ±¸ÃàÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ¿äÄÁ´ë, ¹è´¢¹é ½ÃÀåÀº Àα¸Åë°èÇÐÀû º¯È­¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÇ º¯È­¿¡ ÈûÀÔ¾î ²ÙÁØÇÑ ¼ºÀå ±Ëµµ¸¦ ±×¸®°í ÀÖÀ¸¸ç, ±â¼ú Çõ½Å°ú Àü·«Àû Á¦ÈÞ¿¡ Áö¼ÓÀûÀ¸·Î ÁýÁßÇÏ¸é °­·ÂÇÑ »ç¾÷ È®ÀåÀÇ ±æÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 14¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 15¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 23¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 6.64%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¹è´¢¹é ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¹è´¢¹é ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ºñ´¢±â °¨¿°°ú ¿¬°üµÈ ³ëÀÎ Àα¸ÀÇ Áõ°¡
    • ºñ´¢±â°ú ¹× ºÎÀΰú ¼ö¼ú °Ç¼ö Áõ°¡
    • °íÇ÷¾Ð ¹× ´ç´¢º´ ȯÀÚ Áõ°¡·Î ÀÎÇÑ ¸»±â ½ÅÀå ÁúȯÀÇ À¯Çà
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ¹è¾×¹é »ç¿ëÀ¸·Î ÀÎÇÑ ¿ä·Î °¨¿° ¹× ÇǺΠÀÚ±Ø À§Çè
  • ½ÃÀå ±âȸ
    • ¿ä½Ç±Ý Ä¡·á¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇÑ ±â°ü ¹× ¹Î°£ ±â¾÷ÀÇ ³ë·Â Áõ°¡
    • ºñ¿ë È¿À²ÀûÀÎ »õ·Î¿î ¹è¼ö ¹éÀ» °³¹ßÇϱâ À§ÇÑ R&D ºñ¿ë Áõ°¡
  • ½ÃÀå °úÁ¦
    • °³¹ßµµ»ó±¹ ¹× Àα¸°¡ ÀûÀº ÀϺΠÁö¿ªÀÇ ÀÎ½Ä ºÎÁ·

Porter's Five Forces : ¹è´¢¹é ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¹è´¢¹é ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¹è´¢¹é ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¹è´¢¹é ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

¹è´¢¹é ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¹è´¢¹é ½ÃÀå¿¡¼­ÀÇ °ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¹è´¢¹é ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ¹è´¢¹é ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æ ã±â

¹è´¢¹é ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¹è´¢¹é ½ÃÀå ¹é À¯Çüº°

  • ·¹±× ¹é
  • ·¹±Ö·¯ ¹é ¶Ç´Â ¶óÁö ¹é

Á¦7Àå ¹è´¢¹é ½ÃÀå ¿ëµµº°

  • ÀÏȸ¿ë
  • Àç»ç¿ë °¡´É

Á¦8Àå ¹è´¢¹é ½ÃÀå : ¿ë·®º°

  • 0-500ml
  • 1000-2000ml
  • 500-1000ml

Á¦9Àå ¹è´¢¹é ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Ŭ¸®´Ð
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¹è´¢¹é ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹è´¢¹é ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¹è´¢¹é ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Amsino International, Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Coloplast Corp.
  • Cook Group Incorporated
  • Flexicare(Group) Limited
  • Healthium Medtech Limited
  • Hollister Incorporated
  • Jolfamar XXI, SL
  • Manfred Sauer UK Ltd.
  • McKesson Medical-Surgical Inc.
  • Medline Industries, LP
  • Medtronic PLC
  • Pacific Hospital Supply Co., Ltd.
  • Poly Medicure Limited
  • Teleflex Incorporated
  • UROMED Kurt Drews KG
  • Wujiang Evergreen EX/IM Co., Ltd.
ksm 24.11.29

The Urinary Drainage Bags Market was valued at USD 1.49 billion in 2023, expected to reach USD 1.58 billion in 2024, and is projected to grow at a CAGR of 6.64%, to USD 2.34 billion by 2030.

The urinary drainage bag market is defined by products designed to collect urine from patients requiring assistance due to surgeries, chronic medical conditions, or aging. These bags come in different varieties, including leg bags, bedside bags, and large-capacity drainage bags, aligning with various patient needs and settings. The necessity of urinary drainage bags stems from their critical application in hospital, ambulatory, and home care settings, providing comfort to patients and convenience for caregivers. With a growing aging population and rising incidences of urinary disorders, the market's end-use scope spans clinics, hospitals, and long-term care facilities. Emerging growth factors influencing the market include technological advancements in catheter materials, enhancing patient comfort and reducing the risk of infections. Additionally, increasing healthcare expenditures, coupled with a heightened focus on home care due to the COVID-19 pandemic, are amplifying market demand. However, limitations such as product recalls, the potential for urinary tract infections, and discomfort or stigma associated with usage pose challenges. Despite these challenges, the market presents several opportunities: expanding product portfolios with smart monitoring systems can significantly benefit patient outcomes, and innovating eco-friendly, biodegradable materials can align products with sustainable practices. Moreover, developing better user-centric designs that prioritize ease-of-use and discretion could boost market acceptance. For companies aiming to lead, investing in R&D to innovate antimicrobial technologies and integrated digital solutions for real-time monitoring presents a strong path forward, especially in home care solutions. To effectively capture the evolving market landscape, it is crucial to keep abreast with regulatory frameworks and forge partnerships with healthcare providers. In essence, the urinary drainage bag market exhibits a steady growth trajectory, driven by demographic shifts and healthcare delivery transformations, with a sustained focus on innovation and strategic collaboration offering avenues for robust business expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 1.49 billion
Estimated Year [2024] USD 1.58 billion
Forecast Year [2030] USD 2.34 billion
CAGR (%) 6.64%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Urinary Drainage Bags Market

The Urinary Drainage Bags Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in geriatric population coupled with urinary infection diseases
    • Growing number of urological and gynecological surgeries
    • Prevalence of end-stage renal diseases due to rising cases of hypertension and diabetes
  • Market Restraints
    • Risk of urinary tract infections and skin irritation associated with use of drainage bags
  • Market Opportunities
    • Increasing initiatives by organizations and private players to raise awareness regarding incontinence care
    • Rising expenditures in R&D to create cost-effective and novel drainage bags
  • Market Challenges
    • Lack of awareness in some parts of developing and most the underdeveloped regions

Porter's Five Forces: A Strategic Tool for Navigating the Urinary Drainage Bags Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Urinary Drainage Bags Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Urinary Drainage Bags Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Urinary Drainage Bags Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Urinary Drainage Bags Market

A detailed market share analysis in the Urinary Drainage Bags Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Urinary Drainage Bags Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Urinary Drainage Bags Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Urinary Drainage Bags Market

A strategic analysis of the Urinary Drainage Bags Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Urinary Drainage Bags Market, highlighting leading vendors and their innovative profiles. These include Amsino International, Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Coloplast Corp., Cook Group Incorporated, Flexicare (Group) Limited, Healthium Medtech Limited, Hollister Incorporated, Jolfamar XXI, SL, Manfred Sauer UK Ltd., McKesson Medical-Surgical Inc., Medline Industries, LP, Medtronic PLC, Pacific Hospital Supply Co., Ltd., Poly Medicure Limited, Teleflex Incorporated, UROMED Kurt Drews KG, and Wujiang Evergreen EX/IM Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Urinary Drainage Bags Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Bag Type, market is studied across Leg Bag and Regular or Large Bag.
  • Based on Usage, market is studied across Disposable and Reusable.
  • Based on Capacity, market is studied across 0-500 ml, 1000-2000 ml, and 500-1000 ml.
  • Based on End-User, market is studied across Clinics and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in geriatric population coupled with urinary infection diseases
      • 5.1.1.2. Growing number of urological and gynecological surgeries
      • 5.1.1.3. Prevalence of end-stage renal diseases due to rising cases of hypertension and diabetes
    • 5.1.2. Restraints
      • 5.1.2.1. Risk of urinary tract infections and skin irritation associated with use of drainage bags
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing initiatives by organizations and private players to raise awareness regarding incontinence care
      • 5.1.3.2. Rising expenditures in R&D to create cost-effective and novel drainage bags
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness in some parts of developing and most the underdeveloped regions
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Urinary Drainage Bags Market, by Bag Type

  • 6.1. Introduction
  • 6.2. Leg Bag
  • 6.3. Regular or Large Bag

7. Urinary Drainage Bags Market, by Usage

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Urinary Drainage Bags Market, by Capacity

  • 8.1. Introduction
  • 8.2. 0-500 ml
  • 8.3. 1000-2000 ml
  • 8.4. 500-1000 ml

9. Urinary Drainage Bags Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Hospital

10. Americas Urinary Drainage Bags Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Urinary Drainage Bags Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Urinary Drainage Bags Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amsino International, Inc.
  • 2. Becton, Dickinson and Company
  • 3. Cardinal Health, Inc.
  • 4. Coloplast Corp.
  • 5. Cook Group Incorporated
  • 6. Flexicare (Group) Limited
  • 7. Healthium Medtech Limited
  • 8. Hollister Incorporated
  • 9. Jolfamar XXI, SL
  • 10. Manfred Sauer UK Ltd.
  • 11. McKesson Medical-Surgical Inc.
  • 12. Medline Industries, LP
  • 13. Medtronic PLC
  • 14. Pacific Hospital Supply Co., Ltd.
  • 15. Poly Medicure Limited
  • 16. Teleflex Incorporated
  • 17. UROMED Kurt Drews KG
  • 18. Wujiang Evergreen EX/IM Co., Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦